KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Depreciation ExpenseEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsShares Issued
Ratios

Pacific Biosciences Of California (PACB) Long-Term Debt Repayments (2020 - 2024)

Historic Long-Term Debt Repayments for Pacific Biosciences Of California (PACB) over the last 6 years, with Q2 2024 value amounting to $152000.0.

  • Pacific Biosciences Of California's Long-Term Debt Repayments fell 6731.18% to $152000.0 in Q2 2024 from the same period last year, while for Mar 2025 it was $152000.0, marking a year-over-year decrease of 9123.41%. This contributed to the annual value of $490000.0 for FY2024, which is 7339.85% down from last year.
  • Latest data reveals that Pacific Biosciences Of California reported Long-Term Debt Repayments of $152000.0 as of Q2 2024, which was down 6731.18% from $338000.0 recorded in Q1 2024.
  • Pacific Biosciences Of California's Long-Term Debt Repayments' 5-year high stood at $16.0 million during Q1 2020, with a 5-year trough of $152000.0 in Q2 2024.
  • Moreover, its 4-year median value for Long-Term Debt Repayments was $428000.0 (2022), whereas its average is $1.8 million.
  • As far as peak fluctuations go, Pacific Biosciences Of California's Long-Term Debt Repayments soared by 1853.66% in 2023, and later tumbled by 6731.18% in 2024.
  • Quarter analysis of 4 years shows Pacific Biosciences Of California's Long-Term Debt Repayments stood at $16.0 million in 2020, then crashed by 97.32% to $428000.0 in 2022, then increased by 3.97% to $445000.0 in 2023, then tumbled by 65.84% to $152000.0 in 2024.
  • Its Long-Term Debt Repayments stands at $152000.0 for Q2 2024, versus $338000.0 for Q1 2024 and $445000.0 for Q4 2023.